The subject of the order is the delivery of medicinal products for the Institute "CZMP"

Package No. 1

1. Atosibanum; concentrate for solution for infusion 0.0375 g / 5ml 1 vial and 5ml 2 900 vial

Package No. 10

1. Infliximabum, intravenous injections, powder for concentrate for solution for infusion 100 mg, vial 200 vial

Package No. 11 *

1. Immunoglobulinum humanum subcutaneum, subcutaneous injections, solution for injection, 0.2g / ml, vial. 5 ml. IgG content not less than 98%, IgA content below 50mcg / ml, sodium free, storage at room temperature 300 vial

2. Immunoglobulinum humanum subcutaneum, subcutaneous injections, solution for injection, 0.2g / ml, vial. 10 ml. IgG content not less than 98%, IgA content below 50mcg / ml, sodium free, storage at room temperature 450 vial

3. Immunoglobulinum humanum subcutaneum, subcutaneous injections, solution for injection, 0.2g / ml, vial. 20 ml. IgG content not less than 98%, IgA content below 50mcg / ml, sodium free, storage at room temperature 250 vial

4. Immunoglobulinum humanum subcutaneum, subcutaneous injections, solution for injection, 0.2g / ml, vial. 50 ml. IgG content not less than 98%, IgA content below 50mcg / ml, sodium free, storage at room temperature 8 vial

5. Immunoglobulin administration set consisting of: 3-part syringe for 20 ml infusion pumps (luer-lock type) - 1 pc, needle with "butterfly" drain 0.5x15mmx30cm 25G - 1 pc or port with hypodermic needle drug administration with a hose (Neria type) - 1 item, Device for needle-free withdrawal of the preparation from the vial with 0.22 µm filter with the possibility of disinfection before each connection of the syringe - 1 item or needle for withdrawing the drug from the 0.8 or so-called vial. safe with pencil cut and side "window" - 1 item, Sterile gauze 5x5 cm individually wrapped (foil, paper) - 3 items, Sterile dressing for 6 x 7 cm transparent cannulas - 1 item, Alcohol swab for skin disinfection at the injection site and ampoule before taking the preparation - 2 pcs. 1 200 set

6. A plastic container for used medical equipment with a capacity of 2 L with a lockable opening in the lid, 60 pcs.

* The Contractor shall ensure at the price of the offer the lending of pumps for specimen administration and servicing of these devices in an amount of min. 5 items delivered to the Institute as needed.

Package No. 12

1 Toxinum botulinicum type A, intramuscular injection 500 IU, phiol.s.subst. 200 vial

Package No. 13

1 Paricalcitionlum, intravenous injection 5 mcg / 1 ml, phial. 1 ml pack of 5 vials 60 pack

Package No. 14

1. Bosentanum, tabl. 125 mg Pack of 56 tablets 80 op.

Package No. 15

1. Cinacalcetum tablets, the amount of active substance in a 30 mg tablet, pack of 28 tablets 90 op.

2. Cinacalcetum tablets, the amount of active substance in a 60 mg tablet, pack of 28 tablets 75 op.

3. Glatirameri acetas, subcutaneous injection 20 mg / 1 ml, op. 28 ampoules. 15 op.

Package No. 16

1. Interferonum beta 1 a, subcutaneous injections 44 mcg / 1.5 ml, cartridge for 1.5 ml pen, pack of 4 cartridges 72 pack.

2. Peginterferon beta-1a solution for injection in a pre-filled pen pre-treatment kit containing the first 2 doses (63 and 94 micrograms) in adult patients with relapsing-remitting multiple sclerosis. 2 op.

3. Peginterferon beta-1a, solution for injection in a pre-filled pen pre-filled box containing 2 pre-filled pens at 125 micrograms in adult patients with relapsing-remitting multiple sclerosis. 24 op.

Package No. 17

1. Dimethyl fumarate 120 mg capsules for use in adult patients with relapsing-remitting multiple sclerosis. Pack of 14 capsules 8 op.

2. Dimethyl fumarate 240 mg capsules for use in adult patients with relapsing-remitting multiple sclerosis. Packaging 56 capsules 80 op.

Package No. 18

1. Temozolomidum capsules 100 mg op. 5 capsules 240 op.

Package No. 19

1. Surfactantum; zaw.dotchaw./dooskrzl. [0.08 g / ml] x 2 vials and 1.5ml 460 op.

Package No. 2

1. Atosibanum; solution for injection 6.75 mg / 0.9ml 1 vial and 0.9ml, 330 vial

Package No. 20

1. Teicoplaninum; right + solution for shock [0.4 g] x 1 vial.s.subs. (+ comm.) 650 op.

2. Teicoplaninum; right + solution for shock [0.2 g] x 1 vial.s.subs. (+ comm.) 240 op.

Package No. 21

1. Anesthesia gel used for catheterization, sterile (Konix SC001), - 1 x 6 ml applicator 9 600 op.

Package No. 22

1. Aqua sterilisata; irrigation liquid x 1 bottle 1000 ml 16 500 pack

2. Natrii chloridum; irrigation solution; - [9 mg / ml] x 1 bottle of 100 ml 6,000 op.

Package No. 23

1. Omeprazolum; please do.rozt.infuz. [0.04 g] x 1 phial 17 250 op.

2. Ornithinum; solution for infusion [0.5 g / ml] x 10 amp.a 10ml 38 op.

3. Phospholipida essentialia; capsules [0.3 g] x 50 capsules 675 op.

Package No. 24

1 Drops containing at least one strain of microencapsulated Lactobacillus ssp. Bacteria, including L.rhamnosum in an amount of 1 billion / 5 drops or min. 5 billion / 5 drops of live Lactobacillus ssp. Bacteria including L.rhamnosum for children and babies 5 ml bottle. 720 op.

Package No. 25

1 Antithrombinum III; for drip infusion [1,000 IU] x 1 phiol.s.subs. (+ 20ml) 500 op.

Package No. 26

1. Epinephrinum; shock solution [1 mg / ml] x 10 amp.a 1ml 2,000 op.

Package No. 27

1. Ramiprilum; Table. [0.01 g] x 28 tablets 40 op.

2. Ramiprilum; Table. [2.5 mg] x 28 tablets 42 op.

3. Ramiprilum; Table. [5 mg] x 28 tablets 90 op.

4. Torasemidum tabl. 5 mg op. 30 tabl 60 op.

5. Torasemidum tabl. 10 mg op. 30 tabl 30 op.

6. Torasemidum tabl. 20 mg op. 30 tabl 10 op.

Package No. 28

1. Rocuronii bromidum; solution for shock and infusion [0.01 g / ml] x 10 vials and 5ml 500 op.

Package No. 29

1. Carbetocinum; shock solution [0.1 mg / ml] x 5 vials.a 1ml 350 pack.

Package No. 3

1. Atosibanum; solution for injection 75 mg / 10ml 1 vial and 10ml 10 vial

Package No. 30

1. Triptoreline 3.75 prolonged-action lyophilisate for injection 1 phiol. (+ amp-st. with disp. + needles) for use in the drug program for the treatment of precocious puberty in children. 1 100 op.

Package No. 31

1. Thyreptropnum alpha; solution for infusion [0.9 mg / ml] x 2 vials 100 op.

Package No. 32

1. Vancomycinum; injury / infusion. [1 g] x 1 violet.s.subs. 1,000 op.

2. Vancomycinum; injury / infusion. [500mg] x 1 vial.s.subs. 2,500 op.

Package No. 33

1. Carboplatinum; Conclusions for the preparation of the infos [0.01 g / ml] x 1 vial.a 60ml 1000 op.

2. Oxaliplatinum; Conclusions for the preparation of the infos [5 mg / ml] x 1 vial.a 10ml 36 op.

Package No. 34

1. Bevacizumabum; Conclusions for the preparation of the infos [0.1 g / 4ml] x 1 vial. 80 op.

Package No. 35

1. Pemetrexedum; current for concentrate for infusion [1 g] x 1 vial. 50 op.

Package No. 36

1. Methotrexatum; Conclusions for the preparation of the infos [0.1 g / ml] x 1 vial a 50ml 13 op.

2.5-fluorouracilum; solution for shock and infusion [0.05 g / ml] x 1 vial a 100ml 52 pack

3. Irinotecanum; Conclusions for the preparation of the infos [0.02 g / ml] x 1 vial 15 ml 16 op.

Package No. 37

1 Bevacizumabum; Conclusions for the preparation of the infos [0.4 g / 16ml] x 1 vial. 70 op.

Package No. 38

1 Trastuzumabum; shock solution [0.6 g / 5ml] x 1 vial and 5ml 198 op.

Package No. 39

1. Rituximabum; end to owner [0.01 g / ml] x 1 vial 50 ml 30 pack

Package No. 4

1. Ciprofloxacin Kabi 200mg / 100ml, solution.d / inf., 20 bottle 65 op.

2. Ciprofloxacinum; solution for infusion [2 mg / ml] x 1 container 100ml 1 300 op.

3. Ciprofloxacinum; solution for infusion [2 mg / ml] x 1 container 200ml 2 350 op.

4. Ciprofloxacin Kabi 400mg / 200ml, solution.d / inf., 20 bottle 118 op.

5. Ciprofloxacinum; solution for infusion [2 mg / ml] x 1 container 50ml 150 pack.

Package No. 40

1. Cisplatinum; Conclusions for the preparation of the infos [1 mg / ml] x 1 vial.a 100ml 180 pack.

2. Docetaxelum; Conclusions for the preparation of the infos [0.01 g / ml] x 1 vial.a 16ml 140 op.

Package No. 41

1. Fludarabini phosphas; tabl.powl. [0.01 g] x 20 tablets 1 op.

Package No. 42

1. Doxorubicinum lyposomatum nonpegylateum; current for concentrate for infusion [0.05 g] x 2 set and 3 violet 4 op.

Package No. 43

1. Gemcitabinum; Conclusions for the preparation of the infos [0.04 g / ml] x 1 vial a 50ml 60 pack

2. Paclitaxelum; Conclusions for the preparation of the infos [6 mg / ml] x 1 vial a 50ml 700 op.

3. Mitoxantrronum; Conclusions for the preparation of the infos [2 mg / ml] x 1 vial.a 10ml 4 pack.

4. Cyclophosphamidum; current solution for infusion [1 g] x 1 vial.subs. 1 050 op.

5. Doxorubicini hydrochloridum; Conclusions for the preparation of the infos [2 mg / ml] x 1 vial.a 100ml 340 op.

6. Epirrubicini hydrochloridum; Conclusions for the preparation of the infos [2 mg / ml] x 1 vial.a 25ml 149 op.

7. Bleomycini sulphas; Please for solution [15,000 IU / vial] x 1 vial 10a 81 op.

Package No. 44

1. Fligrastminum pegylateum; shock solution [6 mg / 0.6ml] x 1 amp-shot and 0.6ml (blister) 320 op.

Package No. 45

1. Bupivacainum; shock solution [5 mg / ml] x 5 amp.a 4ml 500 op.

Package No. 46

1. Levetiracetamum 100 mg / ml concentrate for solution for infusion 10 amp 5 ml 10 op.

Package No. 47

1. Coffeinum; solution for infusion and oral solution [0.02 g / ml] x 10 amp.a 1ml 75 op.

Package No. 48

1. Calcii folinas; solution for shock and infusion [0.01 g / ml] x 1 vial a 100ml 40 pack

Package No. 49

1. Taurolidini sulphas anticoagulant solution (taurolock); - [40 mg / ml] x 10 amps 5ml 72 op.

Package number 5

1. Furosemidum; shock solution [0.01 g / ml] x 50 amp.a 2ml 1 300 op.

Package No. 50

1. Sevelamerum; tabl.powl. [0.8 g] x 180 tablets 72 op.

Package No. 51

1. Immunoglobulinum humanum normale for intravenous administration of 100 mg in ml, All available volumes according to the needs of the Employer. 2,500 g

Package No. 52

1. Elemental iron in suspension for newborns and premature babies. Product indicated for dietary management to prevent iron deficiency and iron deficiency anemia. Iron content 20 mg / 1 ml. 100 ml container 20 pack.

2. Elemental iron in suspension for newborns and premature babies. Product indicated for dietary management to prevent iron deficiency and iron deficiency anemia. Iron content 10 mg / 1 ml. Container 50 ml 100 pack.

Package No. 53

1. Immunoglobulinum humanum anti-D solution for injection, 50 mcg / ml 1 amp. 1 ml. 200 op.

2. Immunoglobulinum humanum anti-D solution for injection 150 mcg / ml 1 amp. 1 ml. 700 op.

Package No. 54

1. Evolocumabum, solution for injection, 140 mg 1 pen 72 pcs.

Package number 6

1. Ondansetronum; 2mg / ml, solution for shock [2 mg / ml] x 5 amp.a 2ml 8 600 op.

Package No. 7

1. Paracetamol; pink. for infusion 0.01 g / ml x 10 bottles / vial a 100 ml 6,000 op.

Package No. 8

1. Paracetamol; pink. for infusion 0.01 g / ml x 10 bottles a 50 ml 3 200 op.

Package No. 9

1. Darbepoetinum alfa, intravenous and subcutaneous injections 20 mcg. 450 amp-shot

2. Darbepoetinum alfa, intravenous and subcutaneous injections 30 mcg. 300 amp.